Page last updated: 2024-08-24

triazoles and ranolazine

triazoles has been researched along with ranolazine in 10 studies

Research

Studies (10)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (20.00)	29.6817
2010's	6 (60.00)	24.3611
2020's	2 (20.00)	2.80

Authors

Authors	Studies
Gilbert, M; Laustsen, G; Wimett, L	1
Chawla, PS; Kochar, MS	1
Belardinelli, L; Crumb, W; Dhalla, AK; El-Bizri, N; Hirakawa, R; Hu, L; Karpinski, S; Koltun, D; Li, CH; Li, XJ; Liu, G; Rajamani, S; Shryock, JC; Smith-Maxwell, C; Wang, WQ; Wu, L; Yao, L; Zablocki, J	1
Anderson, LL; Bush, WS; Frankel, WN; George, AL; Hawkins, NA; Kearney, JA; Nath, RD; Petersohn, AA; Rajamani, S; Thompson, CH; Vanoye, CG	1
Avila, B; Belardinelli, L; Dhalla, AK; Elzein, E; Jiang, RH; Kalla, R; Kobayashi, T; Koltun, DO; Li, X; Mollova, N; Notte, GT; Parkhill, EQ; Perry, TD; Rajamani, S; Smith-Maxwell, C; Stafford, B; Tang, J; Wang, WQ; Zablocki, JA	1
George, AL; Potet, F; Vanoye, CG	1
Azam, MA; Kusha, M; Labos, C; Lai, PF; Massé, S; Nair, GK; Nanthakumar, K; Tan, NS; Zamiri, N	1
Belardinelli, L; Cerbai, E; Coppini, R; Ferrantini, C; Gentile, F; Matucci, R; Mazzoni, L; Mugelli, A; Olivotto, I; Palandri, C; Pioner, JM; Poggesi, C; Rossi, A; Tesi, C; Tosi, B	1
Burridge, PW; Egecioglu, DE; George, AL; Potet, F	1
Abi-Gerges, N; Cotta, T; Espinoza, A; Geft, V; Ghetti, A; Hernandez, E; Indersmitten, T; Macias, A; Mai, C; Miller, PE; Miron, Y; Nguyen, W; Page, G; Rasoul, L; Stafford, A; Sweat, K; Ton, AT; Truong, K; Wong, T	1

Reviews

1 review(s) available for triazoles and ranolazine

Article	Year
What's new in clinical pharmacology and therapeutics. WMJ : official publication of the State Medical Society of Wisconsin, 2008, Volume: 107, Issue:2 Topics: Abatacept; Acetanilides; Amides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiparkinson Agents; Antirheumatic Agents; Antiviral Agents; Apomorphine; Benzazepines; Cardiovascular Agents; Fumarates; Hepatitis B; Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; Humans; Hypoglycemic Agents; Immunoconjugates; Multiple Sclerosis; Natalizumab; Nucleosides; Papillomavirus Vaccines; Pharmacology, Clinical; Piperazines; Pyrazines; Pyrimidinones; Quinoxalines; Ranolazine; Sitagliptin Phosphate; Smoking Cessation; Telbivudine; Thymidine; Triazoles; Varenicline; Viral Vaccines	2008

Article

Year

What's new in clinical pharmacology and therapeutics.

WMJ : official publication of the State Medical Society of Wisconsin, 2008, Volume: 107, Issue:2

Topics: Abatacept; Acetanilides; Amides; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antiparkinson Agents; Antirheumatic Agents; Antiviral Agents; Apomorphine; Benzazepines; Cardiovascular Agents; Fumarates; Hepatitis B; Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; Humans; Hypoglycemic Agents; Immunoconjugates; Multiple Sclerosis; Natalizumab; Nucleosides; Papillomavirus Vaccines; Pharmacology, Clinical; Piperazines; Pyrazines; Pyrimidinones; Quinoxalines; Ranolazine; Sitagliptin Phosphate; Smoking Cessation; Telbivudine; Thymidine; Triazoles; Varenicline; Viral Vaccines

2008

Other Studies

9 other study(ies) available for triazoles and ranolazine

Article	Year
Drug approvals. The Nurse practitioner, 2007, Volume: 32, Issue:2 Topics: Acetanilides; Alprostadil; Angina Pectoris; Benzazepines; Bone Density Conservation Agents; Diphosphonates; Drug Administration Schedule; Drug Approval; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Enzyme Inhibitors; Fatty Acids; Herpes Zoster Vaccine; Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; Humans; Ibandronic Acid; Insulin; Lubiprostone; Naltrexone; Narcotic Antagonists; Nurse's Role; Papillomavirus Vaccines; Patient Education as Topic; Piperazines; Quinoxalines; Ranolazine; Triazoles; United States; United States Food and Drug Administration; Varenicline	2007
A novel, potent, and selective inhibitor of cardiac late sodium current suppresses experimental arrhythmias. The Journal of pharmacology and experimental therapeutics, 2013, Volume: 344, Issue:1 Topics: Acetanilides; Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiotonic Agents; Cnidarian Venoms; Female; Flecainide; Heart Conduction System; Long QT Syndrome; Mutation; Myocardial Ischemia; Myocytes, Cardiac; Patch-Clamp Techniques; Piperazines; Potassium Channel Blockers; Pyridines; Quaternary Ammonium Compounds; Rabbits; Ranolazine; Sodium Channel Blockers; Triazoles	2013
Antiepileptic activity of preferential inhibitors of persistent sodium current. Epilepsia, 2014, Volume: 55, Issue:8 Topics: Acetanilides; Animals; Anticonvulsants; Cells, Cultured; Female; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; NAV1.2 Voltage-Gated Sodium Channel; Neurons; Piperazines; Pyridines; Ranolazine; Seizures; Sodium Channel Blockers; Triazoles	2014
Discovery of triazolopyridine GS-458967, a late sodium current inhibitor (Late INai) of the cardiac NaV 1.5 channel with improved efficacy and potency relative to ranolazine. Bioorganic & medicinal chemistry letters, 2016, 07-01, Volume: 26, Issue:13 Topics: Animals; Caco-2 Cells; Dose-Response Relationship, Drug; Drug Discovery; Ether-A-Go-Go Potassium Channels; Heart; Humans; Macaca fascicularis; Microsomes, Liver; Molecular Structure; NAV1.5 Voltage-Gated Sodium Channel; Pyridines; Rabbits; Ranolazine; Rats; Sodium Channel Blockers; Structure-Activity Relationship; Triazoles	2016
Use-Dependent Block of Human Cardiac Sodium Channels by GS967. Molecular pharmacology, 2016, Volume: 90, Issue:1 Topics: Anesthetics; Humans; Ion Channel Gating; Lidocaine; Myocardium; Pyridines; Ranolazine; Sodium Channel Blockers; Sodium Channels; Triazoles	2016
Effects of Late Sodium Current Blockade on Ventricular Refibrillation in a Rabbit Model. Circulation. Arrhythmia and electrophysiology, 2017, Volume: 10, Issue:3 Topics: Animals; Calcium; Calcium Channels; Disease Models, Animal; Electric Countershock; Heart Arrest; Logistic Models; Pyridines; Rabbits; Random Allocation; Ranolazine; Reference Values; Sodium Channel Blockers; Sodium Channels; Statistics, Nonparametric; Triazoles; Ventricular Fibrillation	2017
Late sodium current inhibitors to treat exercise-induced obstruction in hypertrophic cardiomyopathy: an in vitro study in human myocardium. British journal of pharmacology, 2018, Volume: 175, Issue:13 Topics: Adrenergic beta-Antagonists; Cardiomyopathy, Hypertrophic; Cohort Studies; Dose-Response Relationship, Drug; Exercise; Female; Humans; Male; Middle Aged; Myocardium; Pyridines; Ranolazine; Sodium; Sodium Channel Blockers; Triazoles	2018
GS-967 and Eleclazine Block Sodium Channels in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes. Molecular pharmacology, 2020, Volume: 98, Issue:5 Topics: Action Potentials; Anti-Arrhythmia Agents; Cells, Cultured; Humans; Induced Pluripotent Stem Cells; Ion Channel Gating; Lidocaine; Myocytes, Cardiac; Oxazepines; Pyridines; Ranolazine; Sodium Channel Blockers; Sodium Channels; Triazoles	2020
Arrhythmogenic and antiarrhythmic actions of late sustained sodium current in the adult human heart. Scientific reports, 2021, 06-08, Volume: 11, Issue:1 Topics: Adult; Atrial Fibrillation; Calcium; Cnidarian Venoms; ERG1 Potassium Channel; Heart Atria; Humans; Membrane Potentials; Models, Cardiovascular; Myocytes, Cardiac; Piperidines; Pyridines; Ranolazine; Sodium; Triazoles	2021